95 results
6-K
EX-99.1
NYMXF
Nymox Pharmaceutical Corp
15 Nov 23
Current report (foreign)
12:00am
of the clinical benefits observed in the long-term extension trial, the Company announced that it intends to meet with regulatory authorities in various … ,
Description
Salaries and bonus
Short-term employee benefits
Stock-based compensation
Total
Total honorariums to the independent directors of the Corporation
6-K
EX-99.1
NYMXF
Nymox Pharmaceutical Corp
14 Aug 23
Current report (foreign)
3:52pm
toxicity nor any significant related molecular side effects in the two studies. As a result of the clinical benefits observed in the long-term … )
Key management personnel compensation is comprised of:
Three months
Six months
ended June 30,
Salaries and bonus
Short-term employee benefits
Stock
6-K
EX-99.1
NYMXF
Nymox Pharmaceutical Corp
12 May 23
Current report (foreign)
4:52pm
any significant related molecular side effects in the 2 studies. As a result of the clinical benefits observed in the long-term extension trial … compensation is comprised of:
Three months
ended March 31,
Salaries and bonus
Short-term employee benefits
Stock-based compensation
NYMOX
6-K/A
EX-99.1
NYMXF
Nymox Pharmaceutical Corp
16 Nov 22
Current report (foreign) (amended)
10:37am
of the clinical benefits observed in the long-term extension trial, the Company announced that it intends to meet with regulatory authorities in various … and bonus
Short-term employee benefits
Stock-based compensation
Total
Total honorariums to the independent directors of the Corporation for participating
6-K
EX-99.1
gjo450ebr
14 Nov 22
Current report (foreign)
4:30pm
6-K
EX-99.1
qfs1sh
15 Aug 22
Current report (foreign)
6:31am
6-K
EX-99.1
oxc3smxncjoo9a
13 May 22
Current report (foreign)
5:14pm
6-K
EX-10.1
majeq58l xj6k
22 Mar 22
Nymox Announces Closing of $6.4 Million Registered Direct Offering
4:43pm
6-K
EX-10.2
2awv6ww og
22 Mar 22
Nymox Announces Closing of $6.4 Million Registered Direct Offering
4:43pm
424B5
3hx1212m
22 Mar 22
Prospectus supplement for primary offering
2:56pm
F-3
EX-10.1
uyhn1 5jottn
9 Dec 21
Shelf registration (foreign)
4:55pm
F-3
bvlxqw
9 Dec 21
Shelf registration (foreign)
4:55pm
6-K
EX-99.1
7u8cpvob6efs88bers2
12 Nov 21
Current report (foreign)
4:40pm
6-K
EX-99.1
hr6h 4kxsb
13 Aug 21
Current report (foreign)
1:32pm
6-K
EX-99.1
uc75ad
14 May 21
Current report (foreign)
3:20pm
6-K
EX-10.2
eegnii2y
6 May 21
Nymox Announces $8,000,000 Private Placement
12:36pm
6-K
EX-10.1
ckl74
6 May 21
Nymox Announces $8,000,000 Private Placement
12:36pm